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Accepted 3 August 2011AbstractObjective: The objective of this study was to demonstrate the diversity of urodynamic findings and temporal effects on bladder dysfunction in
diabetes as well as to evaluate the predisposing factors that attenuate the storage and voiding function of diabetic women.
Material and Methods: In this prospective study, 181 women with type 2 diabetes mellitus (DM) and lower urinary tract dysfunction underwent
complete urogynecological evaluations and urodynamic studies. The patients’ histories of DM and the treatment agents used were documented
from chart records and interviews. The urodynamic diagnoses were recategorized into two groups for comparison, namely overactive detrusor
(detrusor overactivity and/or increased bladder sensation as well as mixed incontinence) and voiding dysfunction (detrusor hyperactivity with
insufficient contractility and detrusor underactivity with poor voiding efficiency) in order to evaluate the temporal effect of DM on diabetic
bladder dysfunction.
Results: The development of bladder dysfunction showed a trend involving time-dependent progression, beginning with storage problems (i.e.
advancing from urodynamic stress incontinence to detrusor overactivity and/or increased bladder sensation) and eventually led to impaired
voiding function. The duration of DM relative to the urodynamic diagnoses of these women was longer in women with voiding dysfunction
(6.8  2.8 years with urodynamic stress incontinence, 7.3  6.5 years with detrusor overactivity and/or increased bladder sensation, and
10.4  8.3 years with women with voiding dysfunction). Notwithstanding these findings, stepwise logistic regression analysis indicated that age
and recurrent urinary tract infections were the two independent factors associated with developing voiding dysfunction.
Conclusion: The urodynamic study revealed a temporal effect on bladder function, and women with diabetic voiding dysfunction were found to
have had a longer duration of DM than women with an overactive detrusor. However, aging and recurrent urinary tract infections are the two
independent factors that contribute to impaired voiding function and diabetic bladder dysfunction.
Copyright  2012, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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The prevalence of diabetes mellitus (DM) has increased
steadily over the past decade in Taiwan. Chang et al [1]* Corresponding author. Department of Obstetrics and Gynecology, Chung
Shan Medical University and Hospital, 110, Section 1, Chien-Kuo North Road,
Taichung 40201, Taiwan.
E-mail address: soocheen@yahoo.com.tw (S.-C. Ng).
1028-4559/$ - see front matter Copyright  2012, Taiwan Association of Obstetri
http://dx.doi.org/10.1016/j.tjog.2012.07.011reported that, from different investigations, 4.9e9.2% of the
Taiwanese population have DM. Our previous survey of the
community-based prevalence of lower urinary tract and pelvic
floor dysfunction also revealed that 5.9% of women aged 20
years or older have DM [2].
DM has reached epidemic proportions worldwide, and
bladder dysfunction is a frequent complication of diabetes,
with a reported prevalence ranging from 25% to 87%, and also
seeming to be related to the duration of DM [3]. In comparisoncs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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affecting around one-third of hemodialysis patients in Taiwan,
which has drawn considerable attention in the past decades
[4], DM-induced lower urinary tract dysfunction has received
far less attention despite having a significant impact on quality
of life and health risks [5].
The most common and bothersome lower urinary tract
complication of DM is diabetic bladder dysfunction.
Compared with controls, women with type 2 DM have a wider
spectrum of lower urinary tract dysfunction, ranging from an
increased risk for nocturia, a weaker urinary stream, smaller
voided volumes, and a lower maximal flow rate through to
diabetic bladder dysfunction with poor emptying and poor
voiding efficiency [6,7]. The incidence of diabetic cystopathy
or diabetic bladder dysfunction ranges from 27% to 85% in
unselected diabetic patients who have undergone routine
urodynamic studies [8].
Clinical features and urodynamic findings have shown that
manifestations of diabetic bladder dysfunction involve not
only a combination of storage and voiding bladder problems,
but also time-dependent change [9]. Recent experimental
evidence from studies of diabetic bladder dysfunction in small
animal models has showna temporal effect on diabetic bladder
dysfunction [10]. In the early phase of bladder dysfunction,
urodynamics reveals impairment or loss of sensation together
with changes in the detrusor reflex. In the later phase,
decompensation of bladder tissue and function results in the
development of impaired detrusor contraction and attenuation
of bladder emptying; these then lead to increasing postvoid
residual urine or urinary retention [10e12].
Furthermore, impaired voiding function can result in
recurrent urinary tract infections or asymptomatic bacteriuria
[13]. Persistent episodes of infection and bacteriuria will
diminish bladder sensation, which causes an increase in
postvoid residual urine and decreased bladder contractility. In
this study, we tried to demonstrate the diversities of urody-
namic findings and evaluate the predisposing factors that
attenuate storage and voiding function in diabetic women who
present with lower urinary tract symptoms.
Materials and methods
In this prospective study from January 2003 to December
2006,we recruited 202 women with type 2 DM and lower
urinary tract dysfunction who had been referred fromeither the
medical or gynecology department to our urodynamic unit. All
these women presented with symptoms of an overactive
bladder with or without urinary incontinence, symptoms of
voiding difficulty, or symptoms of stress urinary incontinence.
All patients underwent a complete urogynecologic evaluation
including a detailed history, a physical examination, urine
analysis, a pad test to quantify urine leakage, and urodynamic
study. The patients’ history of DM and the treatment agents
used were documented from chart records and interviews.
Eight women without a detailed history or complete urody-
namic data and 13 women with a history of anti-incontinence
or a radical hysterectomy for cervical cancer were excludedfrom this study. Finally, 181 women were recruited into this
study. The study protocol was approved by the Institutional
Review Board of Chung Shan Medical University Hospital,
and informed consent was obtained from all patients.
Urodynamic examinations were performed using a Dantec
Duet urodynamic unit (Medtronic, Copenhagen, Denmark) by
a senior technician in an isolated room. Following uro-
flowmetry, the women were placed in the supine position. A 10
Fr catheter was used to drain urine from the bladder to check the
postvoid residual urine volume. The above procedures were
repeated if the summation of the void volume and residual urine
was less than 200 mL. During filling cystometry, the bladder
was filled with sterile water at room temperature at a filling rate
of 30 mL/min.
Next the women changed to a sitting position and urinated
while on a commode that was connected to a flowmeter
(32K10 flow transducer; Medtronic, Copenhagen, Denmark).
Volume at first desire to void (mL), volume at maximal
bladder capacity (mL), maximal detrusor pressure while
voiding (cmH2O), maximal urinary flow rate (mL/s), opening
pressure (cmH2O), opening time (seconds), and electromyo-
gram (EMG) activity (surface EMG) were measured. The
abdominal pressure was recorded using a rectal balloon cath-
eter. Detrusor pressure was calculated by subtracting abdom-
inal pressure from intravesical pressure. A “rest and stress”
(coughing repeatedly every 2e3 seconds) urethral pressure
profile was performed using a dual sensor microtransducer
(5 cm apart) with 200 mL of sterile water in the bladder. The
transducer was withdrawn with the transducer facing the
lateral wall (at the 3 o’clock position) and with a withdrawal
speed of 2 mm/s by an electronic withdrawal device [(32H07)
Puller Mechanism; Dantec].
The terminology for lower urinary tract function and the
description of urodynamic diagnoses used in this study follow
the criteria recommended by the International Continence
Society Standardization Sub-Committee in 2002 [14], except
where specific definitions have been used. Data including age,
menopause, duration of menopause, body mass index, duration
of DM, recurrent urinary tract infections (two episodes of
urinary tract infections in 6 months), and anterior vaginal wall
prolapse above stage II [15] were collected to determine the
factors predisposing towards voiding dysfunction. Urinary
tract infection was diagnosed if patients presented with urinary
tract symptoms such as dysuria, urinary frequency, or fever,
and urine analysis revealed pyuria (> 5 leukocytes per high-
power field in centrifuged sediment) or a positive urine
culture ( 105 colony-forming units/mL). Increased bladder
sensation was defined as a bladder volume at first desire to
void of less than 120 mL and/or a bladder capacity of less than
250 mL. Poor voiding efficiency was defined as a voided
volume of less than 75% of bladder capacity (voided volume
plus postvoid residual urine).
In order to evaluate the temporal effect of DM on diabetic
bladder dysfunction, we reclassified the urodynamic diagnoses
into the two groups for comparison, namely overactive
detrusor and voiding dysfunction. Patients with urodynamic
findings of detrusor hyperactivity with insufficient
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poor voiding efficiency (increased postvoid residual urine
>50 mL or urinary retention) were classified as members of
the voiding dysfunction (impaired voiding function) group.
Patients with urodynamic findings and detrusor overactivity
(and/or increased bladder sensation) and mixed incontinence
were classified as members of the overactive detrusor group.
Data are presented as mean  standard deviation, median,
or percentage depending on the variable. Patient characteristic
variables in each subgroup were compared by one-way anal-
ysis of variance. The Student t test and Chi-square test were
used for comparing differences between groups. Stepwise
logistic regression was used to determine the contributing
factors for voiding dysfunction. A value of p < 0.05 was
considered to be statistically significant.
Results
The mean age and body mass index of our patients was
61.7 years (range 24e87 years) and 26.2 kg/m2 (range
14.8e39.5 kg/m2). Median parity was four, and mean duration
of DM was 8.5 years (range 1e30 years). There were 147
women who were menopausal, 68 women who were suffering
from recurrent urinary tract infections, and 10 women with
anterior vaginal wall prolapse above stage II. The urodynamic
study revealed 20 (11.0%) women who had urodynamic stress
incontinence, 76 (42.0%) women who had detrusor over-
activity and/or increased bladder sensation, 21 (11.6%)
women with mixed incontinence, 49 (27.1%) women who had
detrusor hyperactivity and insufficient contractility, and 13
(7.2%) women with an underactive detrusor with poor voiding
efficiency (Table 1). To control their DM, 2.7% of our patients
used diet as a control, 84.2% were taking oral hypoglycemic
agents, and 9.8% were on insulin.Table 1
Basic characteristics of the women with diabetes mellitus (DM) (n ¼ 181).
Variables n (%)
Age (y), mean  SD (range) 61.7  11.8
(24e87)
Parity, median 4 (0e11)
Menopause 147 (79.9)
Body mass index (kg/m2),
mean  SD (range)
26.2  3.6
(14.8e39.5)
Years of DM, mean  SD (range) 8.5  7.1 (1e30)
Recurrent urinary tract infections 68 (37.0)
Cystocele (þ)a 10 (5.4)
Urodynamic diagnosis
Urodynamic stress incontinence 20 (11.0)
Detrusor overactivity and/or
increased bladder sensation
76 (42.0)
Mixed incontinence 21 (11.6)
Detrusor hyperactivity
and insufficient contractility
49 (27.1)
Underactive detrusor with poor
voiding efficiency
13 (7.2)
Underactive detrusor with
compensation by straining
2 (1.1)
a Cystocele (þ) ¼ anterior vaginal wall prolapse above stage II.During cystometry examination, it was found that, overall,
80.7% of these women with DM had detrusor overactivity and
increased bladder sensation. These consisted of 47 (26.0%)
women with detrusor overactivity, 21 (11.6%) women who
had mixed incontinence, 22 (12.2%) women who had
increased bladder sensation, seven (3.9%) women with both
detrusor overactivity and increased bladder sensation, and 49
(27.1%) women who had detrusor hyperactivity and insuffi-
cient contractility.
The urodynamic study variables of the women with DM
were significantly different for the various subgroups, these
groups being urodynamic stress incontinence, detrusor over-
activity and/or increased bladder sensation, detrusor hyperac-
tivity and insufficient contractility, and underactive detrusor
with poor voiding efficiency. Specifically, diabetic women
with urodynamic stress incontinence were younger, had
a lower body mass index, had had DM for a shorter duration,
had more recently undergone menopause, and had had fewer
recurrent UTIs (Table 2).
In this series, patients with detrusor overactivity and/or
increased bladder sensation, or mixed incontinence, were
clustered as having anoveractive detrusor (n ¼ 97). Women
with impaired voiding function who had detrusor hyperactivity
and insufficient contractility or an underactive detrusor with
poor voiding efficiency were grouped as having voiding
dysfunction (n ¼ 62). The parameters of the urodynamic study
for the voiding dysfunction group showed a lower mean flow
rate (9.0  5.8 vs. 18.9  13.7; p < 0.05), a lower first desire
to void (137.3  48.8 vs.173.1  97.6; p < 0.05), and a pro-
longed opening time (16.4  11.9 vs. 10.0  8.6; p < 0.05).
There was no significant difference between opening pressure,
voiding detrusor pressure, maximal urethral pressure, maximal
urethral closure pressure, and EMG activity before as well as
during voiding between these two groups.
Variables such as age, a longer history of menopause,
a longer history of DM, and recurrent urinary tract infections
were significantly related to voiding dysfunction on univariate
analysis (Table 3). However, stepwise logistic regression
analysis indicated that recurrent urinary tract infection and age
were the two independent factors for developing voiding
dysfunction.
Discussion
Our urodynamic findings demonstrated that the develop-
ment of bladder dysfunction showed a time-dependent
progressive trend beginning with storage problems such as
urodynamic stress incontinence and ranging onward to
detrusor overactivity and/or increased bladder sensation,
eventually leading to impaired voiding function. The duration
of DM among these women with a urodynamic diagnosis was
longer for women with voiding dysfunction (6.8  2.8 years in
urodynamic stress incontinence, 7.3  6.5 years in detrusor
overactivity and/or increased bladder sensation, and
10.4  8.3 years in women with voiding dysfunction). Our
findings are consistent with findings in animal models
[10,12,17,18]. Furthermore, we also found that age and
Table 2
Variables of women with urodynamic stress incontinence (USI), detrusor overactivity and/or increased bladder sensation (DO/IBS), detrusor hyperactivity and
insufficient contractility (DHIC), and detrusor underactivity (DU) with poor voiding efficiency.
USI (n ¼ 20) DO/IBS (n ¼ 97) DHIC (n ¼ 49) DU (n ¼ 13)
Age (years) 57.0  10.9 60.1  11.4 66.3  10.4 65.2  16.4*
Body mass index (kg/m2) 24.2  2.1 26.2  3.8 26.9  3.3 24.7  4.1
Years of diabetes mellitus 6.8  2.8 7.3  6.5 10.4  8.3 11.2  6.6*
Years of menopause 7.0  4.2 11.6  9.3 16.8  9.7 20.3  10.9
Menopause, n (%) 12 (60.0) 74 (76.3) 45(91.8) 12 (92.3)
Recurrent urinary tract infection, n (%) 5 (25.0) 24 (24.7) 36 (53.1) 10 (76.9)*
The variables of the patients’ characteristics in each subgroup were compared by one-way analysis of variance (ANOVA).
* Age, years of diabetes mellitus, and recurrent urinary tract infection showed significant differences among the four subgroups p < 0.05.
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toward the progressive development of voiding dysfunction.
These findings are consistent with previous clinical specula-
tion related to urodynamic findings among diabetic women
[8,11,12,19].
Lifford et al [20] reported that prevalent incontinence and
incident incontinence (relative risk 1.28 and 1.21, respec-
tively) were significantly greater in women with DM than in
women without it. Women with DM have a 2.5-fold increased
risk of urinary incontinence compared with non-diabetic
women (41% vs. 22.1%) [21]. Kebapci et al [19] revealed
that 12.5% of diabetic women with lower urinary tract
symptoms had urodynamic stress incontinence. In the current
study, urodynamic stress incontinence was found in 11.0% of
women with type 2 DM who had lower urinary tract symp-
toms. Women with urodynamic stress incontinence were found
in this study to be younger and to have had fewer recurrent
episodes of urinary tract infection than women with other
types of bladder dysfunction, especially women with voiding
dysfunction (Table 2). However, the increased risk of stress
incontinence in women with DM could not be determined in
our study due to the lack of a control group, and a control
group was not included in our study because of ethical
considerations.
A retrospective study by Yamaguchi et al [22] using
a digitized database of 2300 case records found that 42% of
patients had detrusor overactivity and 14% had increased
bladder sensation. The frequency of detrusor overactivity in
patients with increased bladder sensation was 58%. They
discovered that overactive bladder symptoms, which
commonly occur with diabetic cystopathy and detrusorTable 3
Comparison of the variables in patients with overactive detrusor and voiding
dysfunction.
Overactive
detrusor (n ¼ 97)
Voiding dysfunction
(n ¼ 62)
p
Age (y) 60.1  11.4 66.2  11.8 0.002
Years of diabetes
mellitus
7.3  6.5 10.5  7.9 0.009
Years of menopause 11.6  9.3 17.5  10.0 0.000
Menopausal 74 (76.3) 57(91.9) 0.01
Recurrent urinary
tract infection, n (%)
24 (24.7) 36 (58.1) 0.000overactivity, increased with age, but not with the duration of
diabetes. The prevalence of overactive bladder-related urody-
namic findings was higher in our study than in that of
Yamaguchi et al (80.7% vs. 55%) [22]. Our findings show that
a higher percentage of overactive bladder-related findings
might result from a greater motor or sensory neuropathy of the
bladder in diabetic women. The duration of DM in women
with detrusor overactivity and/or increased bladder sensation
was less than that of women with detrusor hyperactivity and
insufficient contractility (7.3  6.5 years vs. 10.4  8.3 years).
Our results are consistent with the proposed natural history of
progression of DM bladder dysfunction described for the
streptozotocin-induced rat model of DM. Daneshgari et al [10]
hypothesized that storage problems such as detrusor over-
activity or increased bladder sensation occur at an early phase
of bladder dysfunction and voiding problems, and that
a hypocontractile detrusor or impaired detrusor contraction
occurs during the later phase due to decompensated function.
Our previous community survey demonstrated an increased
presence of lower urinary tract dysfunction as age increased
[2]. Haylen et al [23] found that the prevalence of voiding
difficulty was 39% for women who were referred for an initial
urogynecologic assessment including urodynamics. In this
study, 34.3% of diabetic patients had impaired voiding func-
tion, their mean age being 66.2  11.8 years. We found that
patients with impaired voiding function were older
(66.2  11.8 vs. 60.1  11.4 years; p < 0.05) and had a longer
history of DM (7.3  16.5 years vs. 10.5  7.9 years;
p < 0.05).
However, the question remains of whether age is a predis-
posing factor for voiding difficulty in women with DM.
Therefore, we recategorized our patients into an overactive
detrusor group and a voiding dysfunction group. After step-
wise logistic analysis, we found that age and recurrent urinary
tract infections were independent factors for developing
impaired voiding function. However, one of the limitations of
this study is that we did not assess the degree of control of DM
and the occurrence of other systemic diseases in these study
participants, which could theoretically have impacted on the
severity of lower urinary tract symptoms.
Geerlings et al [24] demonstrated that the urothelium in
patients with DM is susceptible to infection, particularly with
Escherichia coli. They found that type I fibrimated Escher-
ichia coli adhered twice as well to diabetic bladders as to
Table 4
Comparison of urodynamic variables in patients with an overactive detrusor
and voiding dysfunction.
Overactive detrusor
(n ¼ 97)
Voiding dysfunction
(n ¼ 62)
p
Voiding time (s) 40.9  25.7 51.2  39.3 0.072
Mean flow rate (mL/s) 18.9  13.7 9.0  5.8 0.000
First desire to void (mL) 137.3  48.8 173.1  97.6 0.009
Vesical pressure (cmH2O) 62.4  24.6 66.3  27.5 0.354
Detrusor pressure 27.0  13.9 26.3  14.7 0.763
Urethral resistance 0.6  0.1 3.5  0.5 0.000
Resting maximal urethral
pressure
97.5  34.5 105.6  53.0 0.287
Resting maximal urethral
closure pressure
97.5  35.6 105.6  53.0 0.173
Opening pressure 26.4  12.6 29.9  15.3 0.201
Opening time 10.0  8.6 16.4  11.9 0.001
EMG activity 0.6  0.7 0.5  0.7 0.441
EMG activity during
opening time
1.2  1.2 0.9  1.1 0.172
In women with diabetes, overactive detrusor was defined as detrusor over-
activity and/or increased bladder sensation, or mixed incontinence.
Voiding dysfunction was defined as detrusor hyperactivity and insufficient
contractility or underactive detrusor with poor voiding efficiency; these were
grouped into the category of voiding dysfunction.
EMG ¼ electromyogram.
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also suggests that asymptomatic bacterial infections and
symptomatic urinary tract infections occur more commonly in
women with DM than nondiabetic controls [25]. Boyko et al
[13] conducted a prospective study and found that diabetic
women had a higher relative risk of urinary tract infection and
asymptomatic bacteriuria (relative risk 1.8 and 2.3, respec-
tively) compared with nondiabetic women. In our study, 37%
of the women with DM had recurrent urinary tract infections,
and 58.1% of the patients with voiding impairment had
experienced recurrent urinary tract infections. Based on our
results, we hypothesize that recurrent urinary tract infections
might cause the progressive development of diabetic bladder
dysfunction, which then progresses from compensated storage
problems to decompensate voiding function.
In this study, we found a significantly lower mean flow rate
and prolonged opening time in the voiding dysfunction group,
but there was no increase in voiding detrusor pressure at
maximal flow and EMG activity before as well as during
voiding (Table 4). A rat model of DM has revealed that there is
less relaxation of the urethral smooth muscle during voiding in
rats with DM than in healthy rats [26]. Deindl et al [27] re-
ported that there are two different pathogenic mechanisms for
urethral obstruction and that both external urethral sphincter
and pelvic floor dysfunction may contribute to dysfunctional
voiding in women. In the current study, our eligible data limit
the further interpretation of whether impaired voiding function
can be attributed to urethral dysfunction in these diabetic
women. Further studies, including a well-designed clinical
study or, probably more usefully, a longitudinal study, need to
be conducted to clarify this issue.
In conclusion, the progression of bladder dysfunction has
a time-dependent trend beginning with storage problems andeventually leading to impaired voiding function. Women with
voiding dysfunction have a longer duration of DM. However,
aging and recurrent urinary tract infections are the two inde-
pendent factors that contribute to impaired voiding function
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